Damai Entertainment Holdings Limited Overview
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Employees at year end (number) | 1,334 | 1,328 | 1,455 | 1,733 | 1,941 |
| Employee benefit expense (RMB M) | 648.7 | 851.6 | 879.7 | 885.2 | 1,007.2 |
Sources: [S1, S2, S3]. FY2021 headcount was 1,163 [S3].
Damai Entertainment is the listed entertainment platform of Alibaba Group. In two years it has moved from a film-centric studio, Alibaba Pictures, to an offline "real-life entertainment" ecosystem anchored by Damai, China's leading live-event ticketing platform. The group monetises entertainment demand at four points. The first is live-event ticketing, on-site services and increasingly self-produced shows. The second is IP licensing and retail through Alifish, which represents Sanrio, Chiikawa, Pokémon and Crayon Shin-chan in China. The third is film ticketing infrastructure (Tao Piao Piao for consumers, Yunzhi for cinemas) together with a now-deliberately conservative film-investment slate. The fourth is drama-series production. FY2026 revenue reached RMB8.0bn, up 20%, with attributable profit of RMB705m. The balance sheet carries roughly RMB10.8bn of cash and deposits and no bank debt. Its strategic edge is Alibaba-ecosystem traffic and payments, near-universal coverage of top-tier Chinese concerts, and IP-licensing scale. Its strategic exposure is concert-supply bottlenecks, film-market volatility, IP-licensor concentration and an early-stage, loss-making international push.
Company's own description (paraphrased from FY2026 filings)
The company describes the group as an integrated platform with content and technology at its core. That platform spans content production; promotion and distribution; IP merchandising, licensing and commercial management; cinema and live-event ticketing management; and internet data services for the entertainment industry [S1]. Management's FY2026 framing is that the group is evolving into a "diversified entertainment platform", powered by technology (notably AI) and organised around offline entertainment consumption [S1, S22].
Independent characterisation
Economically, Damai Entertainment is now best understood as a transaction-and-services platform for offline entertainment, with a content option attached.
-
Platform/take-rate businesses (high margin, capital-light). These are Damai live ticketing (service fees on GMV plus on-site and system fees), Tao Piao Piao (B2C film ticketing) and Yunzhi (B2B cinema ticketing SaaS). The FY2026 live segment earned a 52% segment margin, defined as revenue less cost of sales and allocated selling and marketing [S1].
-
IP licensing and retail (medium margin, growing fastest). Alifish buys China rights to global IPs and sub-licenses them to consumer brands. It has added branded retail stores (Chiikawa flagships) and jointly operates Tmall's pop-toy category on commission. FY2026 segment margin was 18.5% [S1].
-
Content risk-capital (low and volatile margin). This covers film investment, production, promotion and distribution, plus drama-series production. Since FY2026 management has deliberately re-risked film towards small-budget, low-risk projects [S1].
Below the operating line, the group also has a meaningful investment book. It holds 21 equity-method investees (book value RMB736m) and 12 unlisted FVTPL holdings (RMB611m), with YH Entertainment, Shanghai Tingdong Film and Bona Film the largest [S1]. That book has been a recurring source of impairments (RMB427.6m in FY2025) [S1].
Revenue model mix
| Revenue model | Where it sits | Nature | Disclosure status |
|---|---|---|---|
| Transaction/service fees on ticket GMV | Live entertainment; Film content & technology (Tao Piao Piao) | Platform take-rate | Segment-level only; GMV not quantified |
| SaaS/system fees | Yunzhi (cinemas); MAITIX/Maizuo (venues, incl. Galaxy Arena) | B2B software/service | — |
| Content revenue (box office share, distribution fees, rights sales) | Film content & technology; Drama series production | Project-based | Segment-level |
| Licensing fees (sub-licensing) | IP merchandizing (Alifish) | Licensing | Segment-level |
| Product retail | IP merchandizing (Chiikawa stores, self-operated e-commerce) | Product sales | Segment-level |
| Commission (Tmall pop toys) | IP merchandizing | Revenue share | Segment-level |
| Live-event content (promoter income) | Live entertainment content (Xiami Music Entertainment, Mailive, etc.) | Event P&L | Segment-level |
The split by product/service/subscription/licensing is not publicly disclosed beyond segment revenue. FY2024 disclosure split revenue into "point in time" (RMB3,723m) and "over time" (RMB1,310m) recognition [S2]; FY2026 equivalents are not available in the results announcement.
Value-chain position, customers and end-markets
Value chain: Damai sits midstream to downstream (distribution, ticketing, on-site services) and is pushing upstream into content (self-produced concerts, festivals, artist development via the ORCA label) [S1, S12]. In IP it sits between licensors (Sanrio, Chiikawa rights holders, Pokémon, Universal) and licensees/retailers [S1].
Customer types: consumers (ticket buyers, ~300m Damai platform users per company communications [S7]); event organisers and venues; cinemas; brand licensees (THE BEAST, L'Oréal Paris, Chow Tai Fook, MINISO, Pop Mart, Kayou, Yadea named in FY2026) [S1]; and streaming platforms buying drama series. One external customer contributed ~15% of FY2026 revenue (FY2025: none ≥10%) [S1]. The customer is not named. Given related-party trade receivables of RMB1.28bn [S1], it is plausibly an Alibaba-group platform.
End-markets: Mainland China live performance (2025 commercial performance box office RMB61.7bn [S15]), Mainland China cinema box office, Chinese IP licensing and pop-toy retail, long-form drama (streaming), and nascent international ticketing (Southeast Asia, South Korea, Hong Kong/Macau) [S1].
Strategy
Stated strategy (themes from FY2026 annual results and annual report) [S1, S22]
Management's FY2026 language positions the group's evolution from a relatively single business into a cross-industry real-life entertainment platform, with a stated ambition of global leadership [S22]. The three explicit strategic plans are:
-
Overseas expansion. Start with Hong Kong and Macau, then Asia and global markets, integrating overseas ticketing platforms, premium overseas content and leading venue systems [S1].
-
IP commercialisation. Strengthen IP-operation capability across top-tier IP development, merchandise channels and user engagement to scale IP merchandizing [S1].
-
Content leadership and user growth. Extend upstream into live content (raising its revenue and profit contribution); grow users and market share; reinforce the consumer habit of buying tickets on Damai [S1].
Supporting themes are AI throughout the consumer experience (Damai APP upgrade; Miaoya) and a prudent, low-risk posture in film [S1, S7].
The FY2025 renaming rationale emphasised brand refresh towards offline entertainment [S8]. Brokers summarised the FY2025 strategy as four pillars: content leadership, user growth, stronger merchandising capability and overseas expansion [S23].
Strategic initiatives register (last 24 months)
| Initiative | Date | Description | Status |
|---|---|---|---|
| Corporate rebrand to Damai Entertainment | May–Jul 2025 | Name and short-name change | Completed [S8] |
| Damai APP AI upgrade | 21-May-2025 | All-category, AI-driven ticketing service | Live [S7] |
| Maiseat overseas platform | FY2026 | Consumer ticketing in SG/MY/TH/KR | Live, scaling [S1] |
| Overseas hosting/investment | FY2026 | Overseas tours for Mandarin artists (GAI, Zhao Lusi) | Ongoing [S1] |
| ORCA label and global audition | 2-Jul-2026 | Artist development and content production | Launched [S12] |
| Live content brands ("variety + performance" synergy) | FY2026 | Six content brands; incubate proprietary IP | Ongoing [S1] |
| Category expansion | FY2026 | Sports, tourism and exhibitions ticketing | Ongoing [S1, S10] |
| Chiikawa flagship retail | Sep-2025, Apr-2026 | Store model to be replicated across IPs and cities; shift towards experiential formats | Expanding [S1] |
| Miaoya AI design platform (with Tongyi) | FY2026 | AI tool for art-toy designers | Product testing [S9] |
| LuckyLoop proprietary-IP store | FY2026 | Pioneer offline store | Pilot [S9] |
| Shutdown of non-core IP sub-lines | FY2026 | Including Jinli Naqu | Completed, one-off loss [S1, S9] |
| Film strategy reset | FY2026 | Small-budget, low-risk, high-quality slate | Implemented [S1] |
| Galaxy Macau renewal | 15-Oct-2025 | Three-year partnership incl. Macau Pass system upgrade | Active [S11] |
| ESG programme | Ongoing | MSCI AA (2025) | [S14] |
Cost programmes with targets: none publicly announced. S&M fell 6% in FY2026 through "more prudent" marketing [S1].
Management guidance / medium-term targets
The company does not issue quantitative guidance or medium-term financial targets. It states that it expects to fund initiatives from internal resources [S1]. Per the FY2026 earnings call as reported by CICC, management intends to increase investment in FY2027 in international live entertainment, content expansion and self-operated merchandise [S9].
Products & Services
Live entertainment content and technology
| Product / brand | Description | Target customer | Launch / latest | Pricing model | Flagship evidence |
|---|---|---|---|---|---|
| Damai platform & APP | China's leading live-event ticketing platform. Upgraded on 21-May-2025 into an AI-driven, all-category service covering 40+ sub-categories (concerts, festivals, theatre, comedy, exhibitions, sports, tourism, film), 12,000+ cinemas and 20,000 venues; ~300m users per company | Consumers; organisers | Acquired Nov-2023; AI upgrade May-2025 | Service fees on GMV (rate not disclosed) | Ticketed 400,000+ shows in FY2026, double-digit growth [S1, S7] |
| General ticketing agency | Exclusive or general agency for top-tier concerts | Promoters, artists | Ongoing | Agency fees | Covered nearly 100% of top-tier concerts per FY2024 disclosure (Jay Chou, Mayday, Joker Xue, JJ Lin, Jason Zhang) [S2] |
| On-site event services | Ticket allocation, on-site verification, crowd/contingency management | Organisers, large venues | Ongoing | Service fees | ~5,800 large-scale events in FY2026 (+~50% YoY), zero-incident claim [S1] |
| MAITIX / Maizuo ticketing system (international edition) | Digital performance-management and ticketing SaaS | Venues (e.g., Galaxy Arena, Macau) | Intl. edition delivered 2024 | System/service fees | Galaxy Arena (16,000 seats) [S11] |
| Maiseat | Overseas consumer ticketing platform | Consumers in SG, MY, TH, KR | FY2026 | Service fees | Events and buyers "growing rapidly" (unquantified) [S1] |
| Xiami Music Entertainment | Live content brand (concerts/festivals) | Audiences | Existing | Promoter economics | Xiami Music & Arts Festival in Aranya, 4th edition [S1] |
| Mailive | Live content brand | Audiences | Existing | Promoter economics | Not separately quantified |
| Theatre Rocks! (當然有戲) | Drama/theatre content brand | Audiences | Existing | Promoter economics | — |
| Unlimited Art (藝展鴻圖) | Exhibitions brand | Audiences | Existing | Promoter economics | — |
| Ku Xiao Mai (酷小麥) | Live content brand (talk shows and similar) | Audiences | Existing | Promoter economics | — |
| Hao Xi Lian Tai (好戲連台) | Live content brand | Audiences | Existing | Promoter economics | — |
| Major concert promotion | Self-hosted large concerts | Audiences | FY2026 | Promoter economics | Jackson Yee 2025 world tour [S1] |
| Damai International / ORCA | Artist development and content-production label; "All My Anecdotes Global Audition" | Artists, global audiences | 2-Jul-2026 | Label/management economics | Overseas tours for GAI and Zhao Lusi [S1, S12] |
| Hangzhou Asian Games ticketing | Cloud-based digital ticketing system | Event authority | 2,023 | Contract | Exclusive provider [S2] |
| Taomai VIP | Cross-platform membership (Tao Piao Piao + Damai) | Consumers | FY2022 | Membership benefits | Membership "stable and upward" (FY2024) [S2, S3] |
IP merchandizing
| Product / brand | Description | Target customer | Launch / latest | Pricing model | Flagship evidence |
|---|---|---|---|---|---|
| Alifish sub-licensing | Acquires China rights to premium IPs and sub-licenses them to brands; provides IP selection, asset/gallery development, approvals and marketing | Brand licensees | 2,016 | Licensing fees / minimum guarantees (terms not disclosed) | IPs: Sanrio Family, Chiikawa, Pokémon, Universal Studios, Crayon Shin-chan (also Kakao and Saint Seiya earlier); licensees incl. THE BEAST, L'Oréal Paris, Chow Tai Fook, MINISO, Pop Mart, Kayou, Yadea [S1, S2] |
| IP brand retail | Branded flagship and pop-up stores, run directly or licensed to operating partners | Consumers | Shanghai Sep-2025; Hangzhou Apr-2026 | Retail margin / licence | Chiikawa pop-ups in six cities; described as the primary growth driver of the segment [S1] |
| Tmall pop-toy category joint operation | Co-operation of Tmall's pop-toy category | Merchants/consumers | Ongoing | Commission-based revenue share | FY2022 pop-toy GMV contribution +57% [S1, S3] |
| Self-operated e-commerce flagships | Online stores for IP retail brands | Consumers | Ongoing | Retail | — |
| Miaoya (妙呀) | AI design platform for art-toy designers, built with Alibaba's Tongyi | Designers | FY2026 (product testing) | — | Used to generate the FY2026 annual report cover [S9, S22] |
| LuckyLoop | Offline "pioneer" store exploring proprietary IP | Consumers | FY2026 | Retail | Per earnings call [S9] |
| KOITAKE | Proprietary pop-toy brand; 10+ self-produced IPs (e.g., Kayla-X, PiPi) integrated with 40+ film/TV titles | Consumers | FY2022 | Retail | [S2, S3] |
| KOILAND | IP retail store concept (online + offline) | Consumers | FY2022 | Retail | — |
| Jinli Naqu (錦鯉拿趣) | Collectible cards / non-core sub-line | Consumers | — | — | Shut down in FY2026 with a one-off loss [S1, S9] |
Film content and technology
| Product / brand | Description | Target customer | Launch / latest | Pricing model | Flagship evidence |
|---|---|---|---|---|---|
| Tao Piao Piao | B2C movie ticketing app | Cinema-goers | Long-standing | Service fees | Stable market share in FY2026 [S1] |
| Yunzhi | Cloud cinema ticket-issuing system | Cinemas (incl. Macau and Southeast Asia) | Long-standing | System fees | #1 nationwide by ticket-issuing cinemas and tickets issued [S1, S2] |
| Beacon / Beacon AI (燈塔) | Data and AI product: box-office prediction (T+3 and total), marketing Q&A, public-opinion analysis, AI marketing materials | Studios, distributors | Beacon AI 2023 | Subscription/service (not disclosed) | [S2] |
| Virtual filming / virtual studios | Digital production technology | Producers | Ongoing | Service | [S1, S2] |
| Leah (厘里) digital human | Digital actress / brand ambassador | Brands, productions | 2,022 | Commercial deals | Appeared in Youku dramas and reality shows [S2] |
| Film investment, production and distribution | Co-production, self-production, lead promotion and distribution | Cinemas/audiences | Ongoing | Box office share / distribution fees | FY2026: The Shadows' Edge (#3 summer 2025) and Scare Out (#2 spring 2026) [S1]. FY2024: 60+ films, >60% of box office, 15 of top 20 [S2]. FY2022: 44 films, 71% of domestic-film box office [S3] |
| HINA International Young Director Program | Talent incubation with Zhang Yimou, Huang Jianxin and Bill Kong as mentors | Directors | FY2024 | — | 20 directors recruited [S2] |
| Film | Box office CNY Bn | Role |
|---|---|---|
| No More Bets | 3.85 | Co-producer |
| Lost in the Stars | 3.52 | Co-producer, lead distributor |
| YOLO | 3.46 | Main producer and distributor |
| Pegasus 2 | 3.39 | Joint producer/distributor |
| Boonie Bears: Time Twist | 1.99 | Joint producer/distributor |
| Chang'an | 1.83 | Joint producer, lead distributor |
FY2024 film slate box office (selected, RMB bn) [S2]
Recent and upcoming titles cited by the company or brokers include Love Letters to Grandma (Lan Hongchun), which CICC expects to contribute to FY2027 profit [S9, S16]. Broker notes from November 2025 also reference titles scheduled around January 2026, with English titles rendered inconsistently across sources [S17].
Drama series production
| Product | Description | Status (FY2026) |
|---|---|---|
| In the Name of Justice (以法之名) | Legal drama | Broadcast [S1] |
| Wild Ambition Bloom (灼灼韶華) | Drama | Broadcast [S1] |
| Unveil: Jadewind (唐宮奇案之青霧風鳴) | Period mystery | Broadcast [S1] |
| Prosecutor (追訴), Transfer Gold Hairpin (嫁金釵), Doctor's Honor (醫生榮譽) | Various | Filmed, awaiting release [S1] |
| Pipeline | Studio slate | 20+ key projects [S1] (35 projects cited in FY2024 [S2]) |
| Historical hits | Be Reborn, Because of Love, The Story of Hua Zhi, Pegasus | [S2, S3] |
Pricing for drama series (licence fees to platforms) is not publicly disclosed. A connected-transaction cap under the Commissioned Production Cooperation Framework Agreement (with Alibaba-group parties) was raised from RMB100m to RMB200m for FY2026, signalling higher volumes commissioned by related platforms [S21].
Financial Narrative
Basis: audited HKFRS figures. FY2023 income-statement figures are the restated continuing-operations figures shown in [S2]; FY2023 as originally reported had revenue of RMB3,520.4m [S5]. FY2021 is shown in the commentary only.
Income statement — chartable
Sources: [S1, S2, S3]. The FY2023 adjusted EBITA was originally reported as ~RMB295m [S5 annual report] and re-presented as RMB312.9m in [S2].
Derived EBITDA method: operating profit plus depreciation of PP&E, depreciation of right-of-use assets, depreciation of investment property, and amortisation of intangibles, all taken from the "expense by nature" notes. FY2023 and FY2024 notes do not separately show investment-property depreciation, so EBITDA for those years is understated slightly.
Margins and growth — chartable (derived)
FY2023 growth is measured against FY2022 as originally reported.
Revenue CAGR (derived): FY2022→FY2026 (4 years) 21.8%. FY2021→FY2026 (5 years, RMB2,858.9m → RMB8,024.4m) 22.9%.
Balance sheet — chartable
Sources: [S1, S2, S3]. The FY2022 cash line includes no term-deposit breakdown in [S3].
The company's own "cash and cash equivalents and bank deposits with maturity within one year" metric was RMB5,688m at FY2026 (FY2025: RMB3,365m; FY2024: RMB6,715m) [S1, S2]. The broader derived figure above adds deposits with maturity beyond one year (RMB3,458m at FY2026) and structured deposits (RMB1,728m).
Cash flow
Cash-flow proxy (derived): derived gross cash rose from RMB8,400m to RMB10,838m (+RMB2.44bn) in FY2026, with no equity raise and RMB397m of borrowings repaid. This implies strong cash generation, aided by the rise in ticketing float (+RMB1.09bn in event-ticket payables) and contract liabilities (+RMB0.63bn). It should not be read as recurring free cash flow.
Commentary on trends, inflections and drivers
FY2021–FY2023: pandemic volatility.
-
The film-heavy model swung from a FY2021 loss (attributable −RMB96m) to the company's first-ever profit in FY2022 (RMB170m), driven by The Battle at Lake Changjin and a 71% share of domestic-film box office for titles it participated in [S3].
-
It then fell back to a loss in FY2023 (−RMB291m) as Omicron lockdowns hit cinemas [S5].
-
Below the operating line, FY2022 benefited from RMB321m of unlisted fair-value gains, while FY2023 suffered RMB239m of fair-value losses and a RMB131m dilution loss [S2, S3]. The investment book, not the operations, explains much of the profit volatility.
FY2024: structural inflection.
-
Two forces converged: the post-COVID box-office rebound (Mainland box office RMB55.6bn over the fiscal year, +75%) and the November 2023 acquisition of Damai [S2].
-
Only four months of Damai contributed RMB394m of revenue and RMB224m of net profit, an extraordinary profit density [S2].
-
Pro-forma adjusted EBITA would have been RMB1.16bn against a reported RMB504m [S2].
-
Acquisition accounting is notable: consideration of RMB1,192m against net identifiable assets of RMB1,188m produced goodwill of only RMB3.8m. This reflects that Damai was acquired at a valuation close to its net cash and ticket-float-rich balance sheet [S2].
FY2025: scale-up with noise.
-
Revenue rose 33% to RMB6.7bn with a full year of Damai, and adjusted EBITA rose 61% to RMB809m [S4].
-
Adjusted EBITA included a non-recurring RMB160m reversal of a historical receivable impairment; excluding it, adjusted EBITA was RMB649m [S1].
-
Reported profit was weighed down by a RMB428m impairment of equity-method investments [S1].
-
Goodwill rose by ~RMB289m and intangibles by ~RMB224m. This implies one or more FY2025 business combinations not identified in the documents reviewed (flagged for verification against the FY2025 annual report).
FY2026: quality of earnings improves; core margin compresses.
-
Attributable profit nearly doubled to RMB705m [S1]. Contributors:
-
no equity-investment impairment, versus RMB428m in FY2025;
-
higher other gains (RMB238m, including RMB76m from disposals of associates' stakes);
-
film profitability recovering from RMB73m to RMB310m of segment results.
-
-
Pre-tax profit therefore rose from RMB294m to RMB956m, although a normalised tax charge (RMB263m versus a RMB92m credit) absorbed part of the gain [S1].
-
Adjusted EBITA fell 8% reported but rose 15% excluding the FY2025 one-off [S1].
-
Gross margin slid for a second year (40.1% → 37.0% → 34.5%) as lower-margin IP retail, drama and live-content activities grew faster than high-margin ticketing.
-
Administrative expenses rose 21% to RMB1.50bn with international and new-business build-out [S1].
Watch item: FY2026 adjusted EBITA (RMB746m) is roughly equal to segment results (RMB2,047m) less administrative expenses (RMB1,502m) plus share-based compensation. Further margin expansion therefore depends on overhead leverage, which management signalled will remain under pressure in FY2027 because of continued international, content and self-operated retail investment [S9].
Balance sheet:
Fortress liquidity: Derived gross cash of RMB10.8bn equals ~42% of total assets, with zero bank debt at FY2026 [S1].
Ticket float: Event-ticket payables of RMB3.9bn are customer money owed to organisers, so "excess" cash is lower than headline.
Receivables quality is a persistent weakness: Trade receivables over 365 days were RMB889m (31% of gross), with an allowance of RMB188m [S1]. Other receivables carry a further RMB330m allowance [S1].
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Key products/brands |
|---|---|---|
Live entertainment content and technology business (renamed from "Damai ticketing and live entertainment platform") | Full live-event lifecycle: venue operations, organisation, investment, production and promotion of shows, ticketing, on-site services, ticketing systems, international business | Damai platform/APP, MAITIX/Maizuo, Maiseat (overseas), Xiami Music Entertainment, Mailive, Theatre Rocks!, Unlimited Art, Ku Xiao Mai, Hao Xi Lian Tai, Damai International / ORCA |
IP merchandizing | Sub-licensing, IP-brand retail, joint operation of Tmall pop-toy category, self-operated e-commerce, IP innovation | Alifish, Chiikawa flagship stores, Miaoya AI design platform, LuckyLoop store |
Film content and technology business (renamed from "film technology and investment, production, promotion and distribution platform") | Film investment, production, promotion and distribution; Tao Piao Piao and Yunzhi ticketing; virtual filming | Tao Piao Piao, Yunzhi, Beacon AI, film slate |
Drama series production | Investment in and production of drama series | Studio slate (20+ key projects) |
Segment revenue (CNY Mn)
| Segment revenue (CNY Mn) | FY2025 | FY2026 |
|---|---|---|
Live entertainment content and technology | 2,057.2 | 2,275.5 |
IP merchandizing | 1,355.5 | 2,169.5 |
Film content and technology | 2,711.8 | 2,178.4 |
Drama series production | 577.8 | 1,401.0 |
Total revenue | 6,702.3 | 8,024.4 |
Revenue by Segment
| Segment results (CNY Mn) | FY2025 | FY2026 |
|---|---|---|
Live entertainment content and technology | 1,230.3 | 1,185.8 |
IP merchandizing | 358.9 | 400.4 |
Film content and technology | 73.2 | 309.9 |
Drama series production | 46.9 | 150.6 |
Total segment results | 1,709.2 | 2,046.8 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Revenue
| Segment | FY2026 revenue YoY % | FY2026 results YoY % | Margin FY2025 % | Margin FY2026 % | Revenue share FY2025 % | Revenue share FY2026 % |
|---|---|---|---|---|---|---|
Live entertainment content & technology | 10.6 | -3.6 | 59.8 | 52.1 | 30.7 | 28.4 |
IP merchandizing | 60.1 | 11.6 | 26.5 | 18.5 | 20.2 | 27.0 |
Film content & technology | -19.7 | 323.3 | 2.7 | 14.2 | 40.5 | 27.1 |
Drama series production | 142.5 | 221.3 | 8.1 | 10.8 | 8.6 | 17.5 |
Group | 19.7 | 19.8 | 25.5 | 25.5 | 100.0 | 100.0 |
Segment revenue (CNY Mn) (FY2023–FY2024)
| Segment revenue (CNY Mn) | FY2023 | FY2024 |
|---|---|---|
Film investment, production, promotion and distribution | 1,229.1 | 2,071.9 |
Film ticketing and technology platform | 522.1 | 920.2 |
Damai (consolidated from 1-Dec-2023) | 0 | 394.3 |
Drama series production | 780.9 | 596.1 |
IP merchandising and innovation initiatives | 968.5 | 1,053.1 |
Total | 3,500.6 | 5,035.7 |
Revenue by Segment (FY2023–FY2024)
| Segment results (CNY Mn) | FY2023 | FY2024 |
|---|---|---|
Film investment, production, promotion and distribution | 263.1 | 467.5 |
Film ticketing and technology platform | 228.5 | 346.4 |
Damai | 0 | 253.3 |
Drama series production | 55.3 | 14.5 |
IP merchandising and innovation initiatives | 223.8 | 243.0 |
Total | 770.7 | 1,324.7 |
Segment revenue (CNY Mn) (FY2021–FY2022)
| Segment revenue (CNY Mn) | FY2021 | FY2022 |
|---|---|---|
Content | 1,424.9 | 1,947.9 |
Technology | 1,127.0 | 1,264.1 |
IP merchandising and commercialization | 307.1 | 440.3 |
Total | 2,858.9 | 3,652.2 |
Revenue by Segment (FY2021–FY2022)
| Segment results (CNY Mn) | FY2021 | FY2022 |
|---|---|---|
Content | 344.4 | 317.5 |
Technology | 461.7 | 430.9 |
IP merchandising and commercialization | 161.2 | 197.1 |
Total | 967.3 | 945.5 |
Revenue by Segment (Half-Yearly)
| Metric (CNY Mn) | 1H FY2025 | 1H FY2026 |
|---|---|---|
Group revenue | 3,051 | 4,047 |
Live content & technology revenue | 1,164 | 1,339 |
IP merchandizing revenue | 566 | 1,160 |
Film content & technology revenue | 1,252 | 1,064 |
Drama series revenue | 61 | 484.3 |
Drama series segment results | -10.9 | 37.8 |
Film content & technology segment results | 122 | 95.2 |
Attributable net profit | 336.6 | 519.5 |
Adjusted EBITA | 642.2 | 549.7 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (CNY Mn) | 3,652.2 | 3,500.6 | 5,035.7 | 6,702.3 | 8,024.4 |
Cost of sales and services (CNY Mn) | 2,157.0 | 2,383.6 | 3,018.7 | 4,224.2 | 5,259.2 |
Gross profit (CNY Mn) | 1,495.1 | 1,117.0 | 2,017.0 | 2,478.1 | 2,765.2 |
Selling and marketing expenses (CNY Mn) | 564.6 | 348.3 | 710.0 | 789.3 | 745.4 |
Administrative expenses (CNY Mn) | 925.5 | 737.3 | 977.9 | 1,237.4 | 1,501.6 |
Operating profit (CNY Mn) | 279.2 | -203.1 | 309.7 | 648.7 | 738.2 |
Adjusted EBITA, non-HKFRS (CNY Mn) | 143.4 | 312.9 | 503.6 | 809.3 | 746.0 |
EBITDA, derived = operating profit + D&A (CNY Mn) | 375.9 | -144.5 | 359.6 | 756.2 | 897.6 |
Finance income, net (CNY Mn) | 79.3 | 116.1 | 181.8 | 193.4 | 245.9 |
Impairment of equity-method investments (CNY Mn) | -218.9 | -127.6 | -112.6 | -427.6 | 0 |
Profit before tax, continuing (CNY Mn) | 128.9 | -254.1 | 300.3 | 294.0 | 955.6 |
Income tax credit or expense (CNY Mn) | 25.4 | 0.4 | 58.6 | 92.4 | -263.4 |
Profit for the year (CNY Mn) | 154.3 | -278.9 | 297.5 | 386.4 | 692.2 |
Profit attributable to owners (CNY Mn) | 169.9 | -291.1 | 284.8 | 363.6 | 705.2 |
Basic EPS (MYR Bn cents) | 0.64 | -1.09 | 1.03 | 1.23 | 2.38 |
Diluted EPS (MYR Bn cents) | 0.64 | -1.09 | 1.03 | 1.23 | 2.35 |
Dividend per share (MYR Bn cents) | 0 | 0 | 0 | 0 | 0 |
Share-based compensation (CNY Mn) | 146.9 | 147.2 | 120.3 | 124.8 | 75.6 |
Film and TV rights impairment in COGS (CNY Mn) | 54.0 | 58.1 | 204.6 | 152.6 | 127.5 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | 27.7 | -4.2 | 43.9 | 33.1 | 19.7 |
Gross margin (%) | 40.9 | 31.9 | 40.1 | 37.0 | 34.5 |
Operating margin (%) | 7.6 | -5.8 | 6.1 | 9.7 | 9.2 |
Adjusted EBITA margin (%) | 3.9 | 8.9 | 10.0 | 12.1 | 9.3 |
EBITDA margin, derived (%) | 10.3 | -4.1 | 7.1 | 11.3 | 11.2 |
Net margin, attributable (%) | 4.7 | -8.3 | 5.7 | 5.4 | 8.8 |
S&M as % of revenue | 15.5 | 9.9 | 14.1 | 11.8 | 9.3 |
Admin as % of revenue | 25.3 | 21.1 | 19.4 | 18.5 | 18.7 |
Balance Sheet
| Metric (as at 31 March) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (CNY Mn) | 15,576.7 | 15,571.6 | 21,459.9 | 23,499.4 | 25,879.9 |
Cash and cash equivalents (CNY Mn) | 3,538.2 | 3,919.5 | 4,413.7 | 2,505.8 | 3,573.6 |
Cash + term/bank deposits + structured deposits, derived (CNY Mn) | 3,538.2 | 4,220.4 | 8,634.3 | 8,400.4 | 10,838.4 |
Short-term borrowings (CNY Mn) | 9.4 | 0 | 0 | 396.7 | 0 |
Long-term borrowings (CNY Mn) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities, total (CNY Mn) | 167.9 | 145.8 | 64.3 | 264.7 | 278.3 |
Net cash excl. leases, derived (CNY Mn) | 3,528.8 | 4,220.4 | 8,634.3 | 8,003.7 | 10,838.4 |
Total equity (CNY Mn) | 14,043.0 | 14,110.2 | 15,820.9 | 16,465.3 | 17,084.9 |
Equity attributable to owners (CNY Mn) | 14,017.1 | 14,069.8 | 15,722.4 | 16,227.6 | 16,832.4 |
Goodwill (CNY Mn) | 3,551.1 | 3,551.1 | 3,554.9 | 3,844.1 | 3,847.9 |
Intangible assets (CNY Mn) | 113.7 | 99.8 | 234.0 | 458.2 | 404.3 |
Current assets (CNY Mn) | 7,861.8 | 8,501.6 | 13,093.7 | 12,138.8 | 15,401.0 |
Current liabilities (CNY Mn) | 1,347.2 | 1,294.5 | 5,523.7 | 6,678.3 | 8,438.1 |
Working capital, derived (CNY Mn) | 6,514.6 | 7,207.1 | 7,570.0 | 5,460.5 | 6,962.9 |
Film and TV rights, current (CNY Mn) | 1,740.7 | 1,834.7 | 2,228.9 | 3,602.4 | 2,991.5 |
Equity-method investments (CNY Mn) | 1,723.2 | 1,827.2 | 1,672.2 | 914.7 | 735.8 |
Financial assets at FVTPL, non-current (CNY Mn) | 1,317.7 | 760.3 | 700.6 | 610.1 | 611.0 |
Payables for distribution of event tickets (CNY Mn) | 0 | 0 | 2,808.3 | 2,846.1 | 3,932.4 |
Contract liabilities (CNY Mn) | 186.3 | 170.4 | 415.0 | 623.0 | 1,257.1 |
Gross trade receivables (CNY Mn) | 1,822.4 | 1,569.5 | 1,964.1 | 2,671.7 | 2,876.6 |
Trade receivables over 365 days (CNY Mn) | 543.7 | 664.6 | 679.8 | 1,007.3 | 888.7 |
Related-party trade receivables (CNY Mn) | 1,170.1 | 942.4 | 1,187.1 | 1,371.2 | 1,276.4 |
Financial Analysis
| Item | FY2022–FY2026 status |
|---|---|
Capex | Indicator: PP&E rose from RMB115m to RMB560m and investment property fell from RMB396m to RMB40m in FY2026, implying a significant reclassification or owner-occupied property; the reason is not explained in [S1] |
Dividends paid | 0 in all years (no dividend declared FY2021–FY2026) [S1, S2, S3] |
Buybacks | None by the company. Share-award trustee market purchases: 11.0m shares (FY2022), 3.0m shares for HK$1.86m (FY2024); none in FY2026 [S1, S2, S3] |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average attributable equity (%) | 1.22 | -2.07 | 1.91 | 2.28 | 4.27 |
ROA on average total assets (%) | 0.99 | -1.79 | 1.61 | 1.72 | 2.80 |
Current ratio (x) | 5.84 | 6.57 | 2.37 | 1.82 | 1.83 |
Debt to equity, bank borrowings (%) | 0.07 | 0 | 0 | 2.41 | 0 |
Asset turnover (x) | 0.235 | 0.225 | 0.272 | 0.298 | 0.325 |
DSO on year-end gross trade receivables (days) | 182 | 164 | 142 | 146 | 131 |
Effective tax rate (%) | -19.7 | 0.2 | -19.5 | -31.4 | 27.6 |
Financial Analysis — Net debt / EBITDA
| Ratio | Value | Note |
|---|---|---|
Net debt / EBITDA | Not meaningful — net cash every year | Net cash of RMB10.8bn at FY2026 ≈ 12x derived EBITDA |
Interest coverage (operating profit ÷ bank + lease interest) | FY2022 22x · FY2023 n/m (operating loss) · FY2024 ~397x · FY2025 ~103x · FY2026 ~58x | Derived from [S1–S3] |
ROIC (derived, FY2026 only) | ~8.6% | NOPAT = RMB738m × (1 − 27.6%) ≈ RMB535m. Invested capital = equity RMB17,085m − derived cash RMB10,838m ≈ RMB6,246m. Highly sensitive to the cash definition |
Cash conversion cycle | Not computed | Inventory and payable-days inputs are distorted by film-rights accounting and ticket float |
Non-current assets excl. financial instruments and deferred tax (CNY Mn)
| Non-current assets excl. financial instruments and deferred tax (CNY Mn) | FY2022 | FY2024 |
|---|---|---|
Mainland China | 3,851.7 | 5,492.9 |
Outside Mainland China (FY2022: USA 5.8 + Hong Kong 0.1; FY2024: "other regions") | 5.9 | 456.8 |
Region Overview
| Region | Trend | Evidence / drivers |
|---|---|---|
Mainland China | Core (~substantially all revenue); growing | National performance box office grew 6.39% in 2025 to RMB61.7bn [S15]. The FY2026 growth drivers were IP retail, drama, live content and Damai GMV [S1] |
Hong Kong & Macau | Priority beach-head for overseas expansion | Strategy explicitly starts with HK/Macau [S1]. Galaxy Macau partnership renewed for three years in Oct-2025, covering Galaxy Arena (16,000 seats), G Box (850) and Broadway Theatre (2,500) [S11] |
Southeast Asia & South Korea | Fastest-growing from a negligible base (unquantified) | Maiseat live in Singapore, Malaysia, Thailand and South Korea [S1] |
Japan, North America | Planned staged validation | Per FY2026 earnings call as reported by CICC [S9] |
Declining regions | None identifiable; overseas business is loss-making in the investment phase | China Galaxy Securities attributes part of the live-segment margin decline to early-stage overseas costs [S10] |
Share Price & Returns
| Horizon | Performance | Notes / source |
|---|---|---|
Latest verified price | HK$0.56 (11-Aug-2026) | [S13 Fintel] |
YTD 2026 (to early Jul-2026) | −43.7% | [S13 MarketScreener] |
1-year | −50.4% (Fintel, to Aug-2026); −53.5% (TradingView, date unspecified) | Sources differ by measurement date [S13] |
3-year | ~+38% (derived: HK$0.405 on ~1-Jun-2023 vs HK$0.56) | Start price from [S23-adjacent: Bamboo Works]; approximate |
52-week range | HK$0.44–1.37 | [S13 MarketScreener] |
Recent peak context | ~HK$0.97–0.99 in Nov-2025 | [S17, S23] |
Valuation Multiples
| Multiple | Damai Ent. | Basis |
|---|---|---|
Market capitalisation | ~HK$16.7bn ≈ RMB15.4bn | 29.88bn shares × HK$0.56 (Fintel: HK$16.6bn) |
P/E (FY2026 basic EPS MYR Bn2.38 cents) | ~21.6x | Derived |
P/B (attributable equity MYR Bn16.83bn) | ~0.91x | Derived |
EV (market cap − derived net cash MYR Bn10.84bn) | ~RMB4.6bn | Derived; excludes adjustment for ticket float |
EV/Sales | ~0.57x | Derived |
EV/EBITDA (derived EBITDA MYR Bn898m) | ~5.1x | Derived |
EV/Sales, float-adjusted (adding back MYR Bn3.93bn ticket payables) | ~1.06x | Derived |
Third-party EV | HK$9.41bn; EV/Sales FY2027E 0.89x; P/E FY2027E 15.9x, FY2028E 12.0x | [S13 MarketScreener] |
Broker-cited adjusted P/E | 18.3x FY2027E / 15.5x FY2028E (at ~HK$0.60, 29-May-2026) | [S9] |
Broker / Aggregator Details
| Broker / aggregator | Rating | Target | Date |
|---|---|---|---|
Fintel average (1-year) | — | HK$0.91 (range ~HK$0.79–1.25) | Aug-2026 |
CICC | Outperform | HK$0.90 (cut from HK$1.32) | 29-May-2026 |
Jefferies | Buy | HK$1.10 (cut from HK$1.43) | 29-May-2026 |
Goldman Sachs | Buy | HK$1.30 (SOTP) | 7-Nov-2025 |
Coverage breadth | ~15 analysts | — | 2026 |
Capital Markets
| Item | Status |
|---|---|
Dividend history | No dividends declared FY2021–FY2026 [S1, S2, S3] |
Dividend policy | No payout policy announced |
Credit ratings (Moody's / S&P / Fitch) | None — the company is not rated |
Debt maturity profile | No bank borrowings at 31-Mar-2026 (RMB396.7m short-term repaid during FY2026). Lease liabilities RMB278.3m (current RMB45.5m; non-current RMB232.8m) [S1] |
Analyst Conclusions
Management guidance
There is no quantitative guidance. Qualitatively, management expects continued growth in its diversified entertainment platform and will fund initiatives internally [S1]. It plans heavier FY2027 investment in international live entertainment, content and self-operated merchandise [S9].
Consensus expectations
Consensus is not fully verified. Indicative points:
-
CICC expects steady domestic performance growth and ~50% IP revenue growth in FY2027, with FY2028 adjusted net profit of ~RMB1.0bn [S9].
-
MarketScreener-implied multiples point to earnings growth from FY2027E to FY2028E (P/E 15.9x → 12.0x) [S13].
Bull case
-
Cash-rich, under-book valuation with growing earnings. At ~0.9x book and ~5x derived EV/EBITDA, the market pays little for a #1 ticketing franchise generating ~RMB1.2bn of segment results.
-
IP retail flywheel. IP revenue grew 60% in FY2026, with the Chiikawa store model replicable. If proprietary IP (Miaoya, LuckyLoop) gains traction, segment margins could rebound from 18.5% towards the 26.5% of FY2025.
-
Earnings quality improving. The film reset lifted segment results from RMB73m to RMB310m, and equity-investment impairments fell to zero. Below-the-line noise is shrinking, so reported EPS should track operations more closely.
Bear case
-
Core platform has peaked. The live segment's results fell 4% in FY2026 and ticketing GMV growth is constrained by concert supply [S1, S10]. Industry growth slowed to ~6% [S15].
-
Structural margin dilution. Growth is coming from lower-margin retail, drama and content, so group gross margin has fallen two years running. International spend will weigh further in FY2027 [S9].
-
Capital-allocation and governance discount. RMB10.8bn of cash earns low returns (ROE ~4.3%) with no dividend. Connected-party dependence and unresolved CG Code deviations persist, and the controlling shareholder's priorities may not align with minorities.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| 1H FY2027 interim results | ~19-Nov-2026 (unconfirmed) | Live segment margin; IP growth versus the +105% 1H FY2026 base; overseas losses |
| INED appointment | Any time | Resolution of CG Code B.2.4(b) |
| Capital return | FY2027 results (~May-2027) | First dividend or buyback from the cash pile |
| Chiikawa/IP store roll-out | Ongoing | New cities and IPs; same-store sales |
| Licence renewals (Sanrio, Chiikawa) | Undisclosed | Any loss or term change |
| Film slate | Spring Festival 2027 | Love Letters to Grandma contribution; new low-budget titles |
| International | Ongoing | Maiseat GMV; HK/Macau share; ORCA artists |
| Concert supply and regulation | Ongoing | Stadium approvals; anti-scalping rules |
| Receivables | Each reporting date | Ageing over 365 days; impairments |
| Alibaba group strategy | Ongoing | Any change in stake, intra-group asset transfers or connected caps |
Analyst verdict
Damai Entertainment has completed one of the cleaner portfolio transformations in Chinese media. In three years it has gone from a loss-making, film-dependent studio (FY2023 attributable loss of RMB291m) to a diversified offline-entertainment platform earning RMB705m. Revenue has grown at a 22% CAGR since FY2022, and the balance sheet holds roughly RMB10.8bn of cash and deposits with no bank debt. The Damai acquisition, bought from the parent at close to net asset value, was transformative. The live segment alone now generates more than half of group segment results.
The market's ~50% de-rating since mid-2025 is not irrational, however. The headline profit doubling in FY2026 was driven largely by the absence of investment impairments, higher disposal gains and a film turnaround. Meanwhile the franchise asset, live ticketing, saw segment results fall. Group gross margin has slipped from 40% to 34.5% as growth migrates into retail, drama and early-stage overseas operations. Management has told investors to expect more, not less, investment in FY2027. Governance is a further overhang: a combined Chair/CEO, a board whose independent directors all exceed nine years' tenure, and growing connected transactions with Alibaba.
The equity is therefore a trade-off between valuation support and earnings-quality uncertainty. At roughly book value and about 5x derived EV/EBITDA, downside is cushioned by cash and a dominant ticketing platform. A re-rating likely requires three things: evidence that live-segment margins have stabilised, IP retail scaling without further margin erosion, and a credible capital-return or disciplined M&A framework for the cash pile. The November 2026 interim results are the next decisive test.
Overall view: Neutral-to-constructive (valuation-supported; awaiting margin inflection). This is an analytical assessment, not investment advice. Readers should verify figures against the primary filings.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Age |
|---|---|---|---|
Fan Luyuan | Executive Director; Chairman & CEO | CEO since 2-Aug-2017; Chairman since 13-Oct-2017 [S3] | 53 per MarketScreener [S13] |
Li Jie | Executive Director; President | Executive Director since at least 2022 [S3] | 51 per MarketScreener [S13] |
Meng Jun | Executive Director; Chief Financial Officer | Since at least 2022 [S3] | — |
Song Lixin (Ms.) | Independent Non-Executive Director; Nomination Committee member from 19-Sep-2025 |
| — |
Tong Xiaomeng | INED |
| — |
Johnny Chen | INED |
| — |
“—” = not publicly disclosed.
Governance Overview
| Dimension | Status |
|---|---|
Board size | 6 (3 executive, 3 INEDs; no non-executive Alibaba nominee currently disclosed) [S1] |
Independence | 50% INEDs; meets the one-third Listing Rule minimum |
Gender diversity | 1 of 6 directors female (Song Lixin) [S1] |
Chair/CEO separation | Not separated — deviation from CG Code C.2.1, explained by the board [S1, S2, S3] |
INED tenure | All three INEDs have served >9 years, triggering CG Code B.2.4(b). No new INED was appointed at the 15-Aug-2025 AGM, and as at 27-May-2026 the company was still identifying a candidate [S1] |
Nomination committee gender | Compliant from 19-Sep-2025 (Song Lixin appointed) [S1] |
Committees | Audit committee reviewed FY2026 results [S1]. |
Model Code compliance | All directors confirmed compliance [S1] |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
19-Sep-2025 | Song Lixin appointed to Nomination Committee | Compliance with new gender-diversity code provision [S1] |
15-Aug-2025 → ongoing | Search for new INED | Long-tenure INED rule; candidate not yet appointed as of May-2026 [S1] |
Between Jun-2024 and May-2026 | Tung Pen Hung no longer listed as NED | — |
Major Shareholders
| Holder | Shares | Stake |
|---|---|---|
Alibaba Group Holding (via Ali CV Investment Holding Ltd) | 13,488,058,846 | ~45.15% (derived) |
Alibaba Group Holding (via Alibaba Investment Ltd) | 2,513,028,847 | ~8.41% (derived) |
Alibaba total | 16,001,087,693 | ~53.56% |
Southbound Stock Connect (aggregate, not a single holder) | ~7,864m (24-Jul-2025) | ~26.32% of tradable shares |
Share award scheme trustee (unvested) | — | ~1.32% of issued shares (May-2025) |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Ticker | Positioning vs Damai |
|---|---|---|---|
Live ticketing (China) | Maoyan Entertainment | 1896.HK | #2 live/film ticketing platform; Tencent and Meituan ecosystem traffic; general agent for Jacky Cheung, Jay Chou, Eason Chan and others in 2025 [S15] |
Live ticketing (China) | Douyin / ByteDance ticketing; Meituan; Trip.com; WeChat mini-programs | Private / 3690.HK / TCOM | Traffic-rich entrants in local and long-tail events (not quantified) |
Live ticketing (international) | Live Nation / Ticketmaster | LYV | Global leader; Q1 2026 revenue US$3.79bn, +12% [S16] |
Live ticketing (HK/Macau/SEA/KR) | Cityline, HK Ticketing, Interpark, KKTIX, regional players | Various | Incumbents in Damai's beach-head markets (not quantified) |
Live content / promoters | Concert promoters (artist-affiliated and independent) | Various | Upstream partners and rivals |
Film ticketing | Maoyan (film ticketing #1 or #2 with Tao Piao Piao) | 1896.HK | Direct duopoly competitor |
Film content | China Film Co.; Bona Film (associate); Enlight Media; Wanda Film; Huace; Tencent Pictures | 600977.SS; 001330.SZ; 300251.SZ; 002739.SZ; 300133.SZ; private | Co-investors and competitors on major titles |
IP licensing / pop toys | Pop Mart; MINISO; Kayou; 52TOYS; Bandai Namco China; licensing agencies | 9992.HK; 9896.HK; private | Pop Mart and MINISO are also Alifish licensees, making them partner-competitors |
Drama | Huace; Linmon Media; Ciwen Media; iQIYI, Tencent Video and Youku in-house studios | Various | Production competitors |
Peer Comparison FY2026
| Metric | Damai Ent. (FY to Mar-2026) | Maoyan (FY to Dec-2025) | Live Nation (Q1 2026 only) |
|---|---|---|---|
Revenue (local, M) | RMB8,024.4 | RMB4,631.5 | US$3,790 (quarter) |
Revenue growth (%) | 19.7 | 13.5 | 12 |
Gross margin (%) | 34.5 | 43.3 | — |
Operating margin (%) | 9.2 | 15.6 | — |
Net margin (%) | 8.6 (profit for year) | 12.2 | — |
Recent Developments
Not identified in sources reviewed: * layoffs, regulatory sanctions or material litigation within the period. Headcount rose 12% in FY2026 [S1].



